Research Output per year
Personal profile
Research Interests
I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.
Training Experience
| 2014 | Residency, Northwestern University, McGaw Medical Center |
| 2018 | Fellowship, Northwestern University, McGaw Medical Center |
Education/Academic qualification
MD, Northwestern University Feinberg School of Medicine
… → 2011
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
Heart Failure
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Anthracyclines
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Registries
Medicine & Life Sciences
Alveolar Rhabdomyosarcoma
Medicine & Life Sciences
Hospitalization
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2011 2019
Inhibitors of Tumor Angiogenesis
Shah, AN. & Gradishar, WJ., 2019, Cancer Chemotherapy, Immunotherapy, and Biotherapy: Principles and Practice, 6th edition. Chabner, B. & Longo, DL. (eds.). Philadelphia: Wolters KluwerResearch output: Chapter in Book/Report/Conference proceeding › Chapter
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
Shah, A. N. & Gradishar, W. J., Jan 1 2018, (Accepted/In press) In : Oncologist.Research output: Contribution to journal › Article
Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
Shah, A. N. & Gradishar, W. J., Aug 17 2018, In : The oncologist.Research output: Contribution to journal › Review article
Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes
Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib
Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.Research output: Contribution to journal › Article
Small Cell Carcinoma
Prostate
Mutation
Organoids
Prostatic Neoplasms
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Santa-Maria, C. A., Kato, T., Park, J. H., Kiyotani, K., Rademaker, A. W., Shah, A. N., Gross, L., Blanco Jr, L. Z., Jain, S., Flaum, L. E., Tellez, C., Stein, R., Uthe, R., Gradishar, W. J., Cristofanilli, M., Nakamura, Y. & Giles, F. J., Apr 10 2018, In : Oncotarget. 9, 27, p. 18985-18996 12 p.Research output: Contribution to journal › Article
Triple Negative Breast Neoplasms
Breast Neoplasms
T-Cell Antigen Receptor
Exome
Granzymes